Details
Stereochemistry | ACHIRAL |
Molecular Formula | Na.H2O.H2O4P |
Molecular Weight | 137.9923 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O.[Na+].OP(O)([O-])=O
InChI
InChIKey=BBMHARZCALWXSL-UHFFFAOYSA-M
InChI=1S/Na.H3O4P.H2O/c;1-5(2,3)4;/h;(H3,1,2,3,4);1H2/q+1;;/p-1
Phosphoric acid, also known as orthophosphoric acid, is used in dentistry and orthodontics to clean and roughen the surfaces of teeth where dental appliances or fillings will be placed. In addition, this acid is a part of product ProcalAmine, which is indicated for peripheral administration in adults to preserve body protein and improve nitrogen balance in well-nourished, mildly catabolic patients who require short-term parenteral nutrition. In combination with dextrose (glucose) and levulose (fructose), phosphoric acid relieves nausea due to upset stomach from intestinal flu, stomach flu, and food or drink indiscretions. In addition, homeopathic product, Brain power contains also phosphoric acid and this product is used to temporarily relieve symptoms of general physical weakness and listlessness, including: fatigue; sore muscles & joints; dry skin; absence of sexual desire; occasional sleeplessness.
Approval Year
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Palliative | PROCALAMINE Approved UseProcalAmine is indicated for peripheral administration in adults to preserve body protein and improve nitrogen balance in well-nourished, mildly catabolic patients who require short-term parenteral nutrition. Launch Date1982 |
|||
Palliative | Unknown Approved UseUnknown |
|||
Palliative | Unknown Approved UseUnknown |
|||
Palliative | Unknown Approved UseUnknown |
|||
Palliative | Unknown Approved UseUnknown |
|||
Diagnostic | Unknown Approved UseUnknown |
|||
Diagnostic | Unknown Approved UseUnknown |
|||
Primary | SODIUM PHOSPHATES INJECTION Approved UseSodium Phosphates Injection, USP, 3mM P/mL, is indicated as a source of phosphorus, for addition to large volume intravenous fluids, to prevent or correct hypophosphatemia in patients with restricted or no oral intake. It is also useful as an additive for preparing specific intravenous fluid formulas when the needs of the patient cannot be met by standard electrolyte or nutrient solutions. The concomitant amount of sodium (4 mEq/mL) must be calculated into total electrolyte content of such prepared solutions. |
PubMed
Title | Date | PubMed |
---|---|---|
Diurnal variation in the levels of glucose and related substances in healthy and diabetic subjects during starvation. | 1967 Feb |
|
Determination of inorganic phosphate in serum and saliva using a synthetic receptor. | 2003 Jun 12 |
|
Amperometric biosensor for determining human salivary phosphate. | 2005 Aug 15 |
|
Phosphorus amendment reduces hepatic and renal oxidative stress in mallards ingesting lead-contaminated sediments. | 2006 Jun |
Patents
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29730
Created by
admin on Fri Dec 15 15:55:33 GMT 2023 , Edited by admin on Fri Dec 15 15:55:33 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
593YOG76RN
Created by
admin on Fri Dec 15 15:55:33 GMT 2023 , Edited by admin on Fri Dec 15 15:55:33 GMT 2023
|
PRIMARY | |||
|
593YOG76RN
Created by
admin on Fri Dec 15 15:55:33 GMT 2023 , Edited by admin on Fri Dec 15 15:55:33 GMT 2023
|
PRIMARY | |||
|
221125
Created by
admin on Fri Dec 15 15:55:33 GMT 2023 , Edited by admin on Fri Dec 15 15:55:33 GMT 2023
|
PRIMARY | RxNorm | ||
|
SUB20076
Created by
admin on Fri Dec 15 15:55:33 GMT 2023 , Edited by admin on Fri Dec 15 15:55:33 GMT 2023
|
PRIMARY | |||
|
m10060
Created by
admin on Fri Dec 15 15:55:33 GMT 2023 , Edited by admin on Fri Dec 15 15:55:33 GMT 2023
|
PRIMARY | Merck Index | ||
|
516949
Created by
admin on Fri Dec 15 15:55:33 GMT 2023 , Edited by admin on Fri Dec 15 15:55:33 GMT 2023
|
PRIMARY | |||
|
4295
Created by
admin on Fri Dec 15 15:55:33 GMT 2023 , Edited by admin on Fri Dec 15 15:55:33 GMT 2023
|
PRIMARY | |||
|
C61947
Created by
admin on Fri Dec 15 15:55:33 GMT 2023 , Edited by admin on Fri Dec 15 15:55:33 GMT 2023
|
PRIMARY | |||
|
DBSALT001971
Created by
admin on Fri Dec 15 15:55:33 GMT 2023 , Edited by admin on Fri Dec 15 15:55:33 GMT 2023
|
PRIMARY | |||
|
CHEMBL1368
Created by
admin on Fri Dec 15 15:55:33 GMT 2023 , Edited by admin on Fri Dec 15 15:55:33 GMT 2023
|
PRIMARY | |||
|
10049-21-5
Created by
admin on Fri Dec 15 15:55:33 GMT 2023 , Edited by admin on Fri Dec 15 15:55:33 GMT 2023
|
PRIMARY | |||
|
100000078328
Created by
admin on Fri Dec 15 15:55:33 GMT 2023 , Edited by admin on Fri Dec 15 15:55:33 GMT 2023
|
PRIMARY | |||
|
DTXSID6073994
Created by
admin on Fri Dec 15 15:55:33 GMT 2023 , Edited by admin on Fri Dec 15 15:55:33 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD